Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis
Objective: To assess the long-term effects including all-cause mortality, cardiovascular mortality, and fracture incidence, of cinacalcet on secondary hyperparathyroidism (SHPT) in patients on dialysis. Methods: PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched fro...
Main Authors: | Yuan Zu, Xiangxue Lu, Jinghong Song, Ling Yu, Han Li, Shixiang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-11-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/504139 |
Similar Items
-
Systemic Immune-Inflammation Index Was Significantly Associated with All-Cause and Cardiovascular-Specific Mortalities in Patients Receiving Peritoneal Dialysis
by: Li G, et al.
Published: (2023-08-01) -
Mean platelet volume and the association with all-cause mortality and cardiovascular mortality among incident peritoneal dialysis patients
by: Jianghai Wang, et al.
Published: (2023-11-01) -
The relationship of platelet distribution width with all-cause and cardiovascular mortality in peritoneal dialysis patients
by: Chunyu Lu, et al.
Published: (2024-12-01) -
Mean platelet volume may predict all-cause and cardiovascular mortality among incident peritoneal dialysis patients
by: Wenyu Jiang, et al.
Published: (2023-12-01) -
Interleukin‐6 levels can be used to estimate cardiovascular and all‐cause mortality risk in dialysis patients: A meta‐analysis and a systematic review
by: Zeyu Chen, et al.
Published: (2023-04-01)